Nanopores are nanometer-sized holes in a substrate. There are two types of nanopores: biological pores composed of proteins or nucleic acids embedded in lipid or polymer membranes, and synthetic pores fabricated in solid substrates. The detection method is electrical monitoring of ion-flow through the pore, as single molecules pass or bind/ interact with the pore. Both nanopore platforms have progressed rapidly over the last decade and significant advances have been made toward DNA and RNA sequencing, early disease diagnosis and a variety of other applications, as reported in a number of talks by leading researchers in the field. Oral presentations were organized into several themes: China government initiative, nanopore sequencing, technological advances, biophysical studies of macro mole cule transport across nanopores and early disease diagnosis. 
China government initiative

Nanopore sequencing
One of the major advantages of nanopore sequencing is the feasibility of sequencing the genome in a short time frame and under US$1000 per genome. The concept is rather simple: as a DNA strand traverses through the pore under an applied voltage, individual bases are identified based on modulations of ion current. However, there were several bottlenecks, such as speed of translocation, spatial and temporal resolution, biophysical properties of the pore and instrumentation. Jens Gundlach (University of Washington, USA) is leading the way of nanopore-based strand-sequencing using MspA nanopores. An enzyme (Phi29 DNA polymerase of helicase) is bound tightly to the singlestranded DNA and in the process, ratchets the DNA through the pore, one nucleobase at a time. However, base calling accuracy needs improvements as several bases in the narrow sensing region of the pore influence the electrical signal and also the enzyme turnover is stochastic. Gundlach's group is developing sophisticated bioinformatics approaches to address these issues toward more accurate nanopore sequencing. One prospective application is whole exosome sequencing as point of care technology. Cynthia Carnes (The Ohio State University, USA) highlighted the need for a rapid low-cost whole exosome sequencing technique that can be integrated with established clinical platforms to understand human arrhythmia pathophysiology and disease treatment. presented advances in developing a hybrid device composed of a solid state pore with a fixed protein machine to study the dynamic properties of a single protein using horseradish peroxidase as an example. Yitao Long (East China University of Science and Technology, China) showed that aerolysin nanopore can resolve 2-nt oligonucleotides and can monitor the cleavage of oligonucleotides by exonuclease-I. His lab also developed a simultaneous optical and electrical detection method for studying different conformations of fluorescently labeled DNA through quartz nanopores. Haichen Wu (Chinese Academy of Sciences) used DNA probes, such as aptamers for sensing metal ions, small organic molecules and biopolymers using α-hemolysin channels. Jia Geng (Sichuan University, China) developed synthetic analogs of biological membrane channels using carbon nanotubes and inserted them into a lipid bilayer as well as cell membrane to serve as a nanopore for transport of ions and biomolecules.
Technological advances
Early disease diagnosis
Early detection is critical for treating many types of diseases, including cancer, bacterial and viral infec-future science group
Advances in nanopore sensing promises to transform healthcare Conference Report tions, and cardiovascular diseases among others. Liquid biopsy of patient body fluids is a rapidly emerging method for detecting biomarkers. While sequencing of DNA is one approach relying on the target molecule passing through the pore, another approach is to functionalize the terminal ends of the pores with programmable probes that can bind a target molecule with high specificity and sensitivity. Farzin Haque (P&Z Biological Technology) presented the concept of capture and fingerprinting of single molecules using nanopores. Programmable receptors can be conjugated in the interior of phi29 nanopores for capturing single chemicals with high specificity and sensitivity. Peptide probes can also be engineered at the terminal ends of the phi29 channel to capture specific antibodies in the presence of many contaminants in the patient serum. Xinghua Lu (Chinese Academy of Sciences) demonstrated how synthetic nanopores can be used to detect DNA origami probes, bound to specific segments of DNA, for genomic diagnosis.
Conclusion
The conference highlighted how advances in nanopore are making new avenues for translating basic science into practical and clinical applications. A round table closed discussion session was held among the invited speakers to brainstorm fundamental challenges and discuss collaborative efforts to solve these challenges. No writing assistance was utilized in the production of this manuscript.
